SCHEMBL7515835

SCHEMBL7515835

CC(C)(C)c1nc(N)c2c(-c3ccccc3)n[nH]c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 3/20 0.42
CDK5 Q00535 2/20 0.42
CDK8 P49336 1/20 0.42
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 3/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 2/20 0.41
HPGD P15428 2/20 0.41
NPC1 O15118 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPT P10636 1/20 0.38
GFER P55789 1/20 0.38
AKT2 P31751 2/20 0.37
GRM5 P41594 1/20 0.37
ALPL P05186 1/20 0.37
IDO1 P14902 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5748863 0.87 MEN1 (0.42) CLK4ALDH1A1KDM4ERAB9AHPGD
SCHEMBL1270136 0.86 CNR1 (0.44) CLK4CDK5CDK8RAB9ANPC1
SCHEMBL7826933 0.85 IKBKB (0.46) CLK4CYP1A2ALPLMAPK10CDK2
SCHEMBL18040266 0.80 DPP4 (0.49) CLK4CDK5ALDH1A1KDM4ERAB9A
SCHEMBL3041138 0.80 MAPK8 (0.43) CLK4CDK5ALDH1A1KDM4ECYP1A2
SCHEMBL8402143 0.79 BTK (0.55)
SCHEMBL6055066 0.78 KDM4E (0.50) ALDH1A1KDM4EGAAHSD17B10KMT2A
SCHEMBL408618 0.73 PIK3CD (0.55) CLK4CDK5ALDH1A1KDM4ERAB9A
SCHEMBL4753476 0.72 CHUK (0.51) CLK4ALDH1A1KDM4ERAB9AGAA
SCHEMBL5065122 0.71 PIK3CD (0.57) CLK4CDK5ALDH1A1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020016976-A1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates PRINCETON UNIVERSITY 2002-02-07 US disclosed
EP-1017823-A2 ENGINEERED PROTEIN KINASES WHICH CAN UTILIZE MODIFIED NUCLEOTIDE TRIPHOSPHATE SUBSTRATES PRINCETON UNIVERSITY (US) 2000-07-12 EP disclosed
WO-1998035048-A2 ENGINEERED PROTEIN KINASES WHICH CAN UTILIZE MODIFIED NUCLEOTIDE TRIPHOSPHATE SUBSTRATES PRINCETON UNIVERSITY (US) 1998-08-13 WO disclosed